PURPOSE: Eyelid myoclonia and absences (EMA) induced by eye closure associated with brief, fast, and generalized paroxysms of polyspikes and waves was considered as an epileptic syndrome and a type of seizure as well. We analyzed the electroclinical features and evolution of EMA, and tried to determine if it represents a well-defined epileptic syndrome or a non-specific condition associated to other epilepsies. METHODS: Between June 1994 and June 2005, 63 patients who met diagnostic criteria of EMA were enrolled in the study and have been followed up to the present time. RESULTS: Two main groups could be identified. The first group was divided into two subgroups. One subgroup of 28 patients presented EMA associated with infrequent generalized tonic-clonic seizures (GTCS), and the other 1 of 9 patients presented early-onset EMA refractory to antiepileptic drugs (AEDs), associated or not with GTCS and mental retardation. Four of them had self-induced seizures. The second group included 26 patients with EMA associated with GTCS and/or massive myoclonias, or GTCS induced by intermittent photic stimulation. All these patients had electroclinical features compatible with idiopathic generalized epilepsies. CONCLUSION: In the first group, EMA should be considered as a photosensitive idiopathic epileptic syndrome. A subgroup of early-onset of EMA refractory to AEDs, associated or not with GTCS and mental retardation should also be considered as a variant or a distinct photosensitive idiopathic epileptic syndrome. Finally, in the second group EMA may correspond to a type of seizures in idiopathic generalized epilepsies.
PURPOSE:Eyelid myoclonia and absences (EMA) induced by eye closure associated with brief, fast, and generalized paroxysms of polyspikes and waves was considered as an epileptic syndrome and a type of seizure as well. We analyzed the electroclinical features and evolution of EMA, and tried to determine if it represents a well-defined epileptic syndrome or a non-specific condition associated to other epilepsies. METHODS: Between June 1994 and June 2005, 63 patients who met diagnostic criteria of EMA were enrolled in the study and have been followed up to the present time. RESULTS: Two main groups could be identified. The first group was divided into two subgroups. One subgroup of 28 patients presented EMA associated with infrequent generalized tonic-clonic seizures (GTCS), and the other 1 of 9 patients presented early-onset EMA refractory to antiepileptic drugs (AEDs), associated or not with GTCS and mental retardation. Four of them had self-induced seizures. The second group included 26 patients with EMA associated with GTCS and/or massive myoclonias, or GTCS induced by intermittent photic stimulation. All these patients had electroclinical features compatible with idiopathic generalized epilepsies. CONCLUSION: In the first group, EMA should be considered as a photosensitive idiopathic epileptic syndrome. A subgroup of early-onset of EMA refractory to AEDs, associated or not with GTCS and mental retardation should also be considered as a variant or a distinct photosensitive idiopathic epileptic syndrome. Finally, in the second group EMA may correspond to a type of seizures in idiopathic generalized epilepsies.
Authors: Carla Marini; Michele Romoli; Elena Parrini; Cinzia Costa; Davide Mei; Francesco Mari; Lucio Parmeggiani; Elena Procopio; Tiziana Metitieri; Elena Cellini; Simona Virdò; Dalila De Vita; Mattia Gentile; Paolo Prontera; Paolo Calabresi; Renzo Guerrini Journal: Neurol Genet Date: 2017-12-11
Authors: Danique R M Vlaskamp; Benjamin J Shaw; Rosemary Burgess; Davide Mei; Martino Montomoli; Han Xie; Candace T Myers; Mark F Bennett; Wenshu XiangWei; Danielle Williams; Saskia M Maas; Alice S Brooks; Grazia M S Mancini; Ingrid M B H van de Laar; Johanna M van Hagen; Tyson L Ware; Richard I Webster; Stephen Malone; Samuel F Berkovic; Renate M Kalnins; Federico Sicca; G Christoph Korenke; Conny M A van Ravenswaaij-Arts; Michael S Hildebrand; Heather C Mefford; Yuwu Jiang; Renzo Guerrini; Ingrid E Scheffer Journal: Neurology Date: 2018-12-12 Impact factor: 11.800